These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37942616)
1. Long-Acting Nanohybrid Hydrogel Induces Persistent Immunogenic Chemotherapy for Suppressing Postoperative Tumor Recurrence and Metastasis. Li Y; Zhu J; Yang Y; Chen Y; Liu L; Tao J; Chen H; Deng Y Mol Pharm; 2023 Dec; 20(12):6345-6357. PubMed ID: 37942616 [TBL] [Abstract][Full Text] [Related]
2. Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy. Fang Y; Huang S; Hu Q; Zhang J; King JA; Wang Y; Wei Z; Lu J; He Z; Kong X; Yang X; Ji J; Li J; Zhai G; Ye L ACS Nano; 2023 Dec; 17(24):24883-24900. PubMed ID: 37883579 [TBL] [Abstract][Full Text] [Related]
3. Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis. Gui J; Zhu Y; Chen X; Gong T; Zhang Z; Yu R; Fu Y Acta Biomater; 2024 Mar; 177():388-399. PubMed ID: 38307476 [TBL] [Abstract][Full Text] [Related]
4. Ferritin-Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy. Liu R; Liang Q; Luo JQ; Li YX; Zhang X; Fan K; Du JZ Adv Sci (Weinh); 2024 Jan; 11(3):e2305217. PubMed ID: 38029345 [TBL] [Abstract][Full Text] [Related]
5. Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis. Hu Y; Xu Y; Mintz RL; Luo X; Fang Y; Lao YH; Chan HF; Li K; Lv S; Chen G; Tao Y; Luo Y; Li M Biomaterials; 2023 Feb; 293():121942. PubMed ID: 36512863 [TBL] [Abstract][Full Text] [Related]
6. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma. Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160 [TBL] [Abstract][Full Text] [Related]
7. Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation. Wang R; Hu Q; Huang S; Fang Y; Kong X; Kaur P; Zhang J; Wang Y; Liu D; Wu H; Li Y; Ji J; Yang X; Ye L; Zhai G ACS Appl Mater Interfaces; 2024 Jan; 16(3):4071-4088. PubMed ID: 38194589 [TBL] [Abstract][Full Text] [Related]
8. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence. Zhuang B; Chen T; Xiao Z; Jin Y Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462 [TBL] [Abstract][Full Text] [Related]
9. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
11. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy. Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma. Yang Z; Liu J; Lu Y Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050 [TBL] [Abstract][Full Text] [Related]
13. PAMAM Dendritic Nanoparticle-Incorporated Hydrogel to Enhance the Immunogenic Cell Death and Immune Response of Immunochemotherapy. Hanurry EY; Birhan YS; Darge HF; Mekonnen TW; Arunagiri V; Chou HY; Cheng CC; Lai JY; Tsai HC ACS Biomater Sci Eng; 2022 Jun; 8(6):2403-2418. PubMed ID: 35649177 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
15. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice. Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma. Karavasili C; Panteris E; Vizirianakis IS; Koutsopoulos S; Fatouros DG Pharm Res; 2018 Jun; 35(8):166. PubMed ID: 29943122 [TBL] [Abstract][Full Text] [Related]
17. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine. Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129 [TBL] [Abstract][Full Text] [Related]
18. In situ gel implant for postsurgical wound management and extended chemoimmunotherapy against breast cancer recurrence. Wang M; Wang S; Pan Y; Yu R; Zhang ZR; Fu Y Acta Biomater; 2022 Jan; 138():168-181. PubMed ID: 34755605 [TBL] [Abstract][Full Text] [Related]
19. Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel. Huang Z; Xiao H; Lu X; Yan W; Ji Z Int J Nanomedicine; 2018; 13():7623-7631. PubMed ID: 30538447 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-nanocrystals-loaded network thermosensitive hydrogel for localised postsurgical recurrent of breast cancer after surgical resection. Fan R; Sun W; Zhang T; Wang R; Tian Y; Zhang H; Li J; Zheng A; Song S Biomed Pharmacother; 2022 Jun; 150():113017. PubMed ID: 35483193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]